Metraipolis › archive › dc_4fa15aec6098

Impact of Sarcopenia and Serum Creatinine on Clinical Outcomes after Tace in Hepatocellular Carcinoma — Europe PMC PMID:42038018

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42038018
DOI
10.7150/jca.127063
License (as archived)
solo-consultazione
Archived
2026-11-03T21:47:52.333Z
SHA-256 of the archived text
6ca4bd7918b0938f02682931057b32d6a7babc83e0e916d9a42c7ae753101be7
Stable URL of this page
https://metraipolis.com/documento/dc_4fa15aec6098

How to cite

Impact of Sarcopenia and Serum Creatinine on Clinical Outcomes after Tace in Hepatocellular Carcinoma — Europe PMC PMID:42038018 — Europe PMC (en), https://europepmc.org/article/MED/42038018 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4fa15aec6098 (Metraipolis archive dc_4fa15aec6098, sha256 6ca4bd7918b0938f02682931057b32d6a7babc83e0e916d9a42c7ae753101be7)
BibTeX
@misc{dc4fa15aec6098,
  title = {Impact of Sarcopenia and Serum Creatinine on Clinical Outcomes after Tace in Hepatocellular Carcinoma — Europe PMC PMID:42038018},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42038018},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4fa15aec6098; sha256 6ca4bd7918b0938f02682931057b32d6a7babc83e0e916d9a42c7ae753101be7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42038018. Agents can read the archived copy with the MCP tool read_document.